People · Operator
Named in public records as an officer, director or promoter · active 2013–2024 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| HistoSonics, Inc. | — | Other Health Care | Series D+ | $308.2M | $1.0B | 2019 |
| G.I. Windows, Inc. | — | Biotechnology | Series B | $76.9M | $218.3M | 2022 |
| Spinal Modulation Inc | — | Other Health Care | Series C | $76.3M | $1.0B | 2013 |
| Hyalex Orthopaedics, Inc. | — | Other Health Care | Series B | $30.4M | $91.1M | 2017 |
| S4 Medical Corp. | — | Biotechnology | Series A | $12.0M | $49.6M | 2021 |
V. Kadir Kadhiresan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside V. Kadir Kadhiresan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Wende Hutton | 1 | 16 |
| Annette Campbell-White | 1 | 11 |
| James Wright | 1 | 9 |
| Christopher Thompson | 1 | 8 |
| Frederic H. Moll | 1 | 8 |
| FRED MOLL | 1 | 8 |
| David Neustaedter | 1 | 7 |
| Roy Tanaka | 1 | 6 |
| Renee Ryan | 1 | 6 |
| Mir Imran | 1 | 6 |
| Linda Tufts | 1 | 5 |
| JAMES ADOX | 1 | 5 |
| Richard M. Ferrari | 1 | 5 |
| Gerry Brunk | 1 | 5 |
| Jon Freeman | 1 | 5 |
| Kadir Kadhiresan | 1 | 4 |
| Brad Vale | 1 | 4 |
| Michael Blue | 1 | 4 |
| William Harrington | 1 | 4 |
| Adam Gridley | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.